Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 17Colorectal Neoplasms 15Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 5Brain Neoplasms 5Skin Neoplasms 4Rectal Neoplasms 4Neoplasms 4Lung Neoplasms 3Neoplasm Metastasis 2Gastrointestinal Neoplasms 2Digestive System Neoplasms 2Thyroid Neoplasms 1Solid Tumors 1Skin Diseases 1Rectal Diseases 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Lymphatic Metastasis 1Leukemia, Hairy Cell 1Intestinal Neoplasms 1Intestinal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Gastrointestinal Diseases 1Disease Progression 1Digestive System Diseases 1Colonic Diseases 1Biliary Tract Neoplasms 1

Interventions

Bevacizumab 2repotrectinib 1encorafenib 1Oxaliplatin 1Oviposition 1Levoleucovorin 1Leucovorin 1Irinotecan 1Fluorouracil 1Drug Therapy 1Drainage 1Cetuximab 1Capecitabine 1Biofeedback, Psychology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Diseases × encorafenib × 1 year × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡